Peter Pitts is president of the Center for Medicine in the Public Interest.
Topics
Appearances (1)
2026-10-08
The Preventable Peptide Crisis: Navigating GLP-1s and the Gray MarketThe rising popularity of GLP-1 medications for weight loss has been accompanied by dangers in the gray market, including counterfeit and unapproved drugs, says Peter Pitts, president of the Center for Medicine in the Public Interest, in a Health Policy Podcast interview with Bryan Hyde. Pitts discusses the health implications of using these drugs without medical supervision and the risks associated with counterfeit and unapproved medications. He emphasizes the importance of FDA oversight and urges consumers to consult healthcare professionals before seeking weight loss solutions online.
Notable quotes
“Being the proper weight is a really important thing to make sure we live longer, healthier lives.”
“GLP-1s are indicated to be used in combination with diet and exercise.”
“The most important consequence is unintended, very negative health consequences for the people that are trying to circumvent the system.”
“Buyer beware. Caveat emptor, you know, is bad pharmaceutical policy.”
“Sometimes a bargain is just too expensive, as my grandmother used to say.”
“If something looks too good to be true, a big red flag should go up.”






